OLDOR study
Phase 3
- Conditions
- Prostate cancer
- Registration Number
- JPRN-jRCTs052220034
- Lead Sponsor
- Tanaka Nobuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 54
Inclusion Criteria
1) Male patients undergoing scheduled robot-assisted laparoscopic radical prostatectomy
2) Patients who were classed as American societyof anesthesiologists performance status (ASA-PS)
1-3
3) Patients aged between 20 and 85 years old
4) Patients who have given written consent to participate in the study
Exclusion Criteria
1) Patients undergoing emergency surgery applied for the day
2) Patients taking beta-blockers, or applying patches for this drug
3) Patients taking oral steroids
4) Patients who cannot secure the measurement site due to a amputation of the finger or lesion on
the nail
5) Patients with inability to give consent
6) Patients who have been judged inappropriate in the study by the investigator or sub-investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method